612069-27-9Azithromycin EP Impurity E
● 在庫あり
| カタログ番号: | VL186007 |
|---|---|
| CAS番号: | 612069-27-9 |
| 分子式: | C36H68N2O12 |
| 分子量: | 720.93 g/mol |
に関する追加情報 CAS 612069-27-9
親薬物
AzithromycinIUPAC名
3-(N,N-didemethyl) Azithromycin同義語
Amino Azithromycin; (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-11-[(3-Amino-3, 4, 6-trideoxy-?-D-xylo-hexopyranosyl)oxy]-13-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)oxy]-2-ethyl-3, 4, 10-trihydroxy-3, 5, 6, 8, 10, 12, 14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one; Aminoazithromycin A; Aminoazithromycin Impurity E (EP) ;Azithromycin Impurity E; USP RRT 0.43Characterization Data (Included)
HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).Additional Characterization Data
QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.説明
Also known as Azithromycin Impurity E, it is an impurity of Azithromycin. Azithromycin is the first member of a group that belongs to macrolide antibiotics called azalides. It is an effective therapeutic agent for the oral treatment of sexually transmitted diseases, upper and lower respiratory tract infections and skin structure infections.References
Kwiecie?, Anna, et al. Stress Degradation Studies on Azithromycin and Development of a Validated Stability-Indicating TLC-Densitometric Method with HPLC/Electrospray Ionization-MS Analysis of Degradation Products.” Journal of AOAC INTERNATIONAL, vol. 95, no. 5, Sept. 2012, pp. 1418–24, https://doi.org/10.5740/jaoacint.10-196.見積もり依頼
「*」は必須フィールドを示します








